OPKO Health Total Assets 2010-2024 | OPK

OPKO Health total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,256
2024-06-30 $1,980
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.051B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.449B 24.45
Intuitive Surgical (ISRG) United States $186.791B 97.66
Edwards Lifesciences (EW) United States $44.123B 28.02
Alcon (ALC) Switzerland $41.807B 27.97
IQVIA Holdings (IQV) United States $35.805B 19.73
IDEXX Laboratories (IDXX) United States $33.758B 39.76
DexCom (DXCM) United States $31.263B 47.08
Waters (WAT) United States $21.860B 32.32
STERIS (STE) Ireland $20.481B 23.58
SONOVA HOLDING (SONVY) Switzerland $19.736B 0.00
Hologic (HOLX) United States $16.260B 17.56
Fresenius Medical Care AG KGaA (FMS) Germany $13.386B 13.74
Sysmex ADR (SSMXY) Japan $11.751B 0.00
Globus Medical (GMED) United States $11.252B 28.49
Penumbra (PEN) United States $9.308B 91.18
Masimo (MASI) United States $9.076B 43.92
Glaukos (GKOS) United States $8.319B 0.00
Teleflex (TFX) United States $8.274B 13.20
Integer Holdings (ITGR) United States $4.484B 25.41
PROCEPT BioRobotics (PRCT) United States $4.236B 0.00
Inari Medical (NARI) United States $3.246B 0.00
Veracyte (VCYT) United States $3.169B 95.09
LivaNova (LIVN) United Kingdom $2.584B 14.92
Nihon Kohden (NHNKY) Japan $2.392B 18.17
Tandem Diabetes Care (TNDM) United States $2.358B 0.00
Elekta AB (EKTAY) Sweden $2.084B 18.74
TransMedics (TMDX) United States $2.071B 65.64
Integra LifeSciences Holdings (IART) United States $1.682B 8.79
RxSight (RXST) United States $1.357B 0.00
Alphatec Holdings (ATEC) United States $1.326B 0.00
Artivion (AORT) United States $1.194B 79.11
Pulse Biosciences (PLSE) United States $1.106B 0.00
Paragon 28 (FNA) United States $0.840B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.739B 12.56
Mesa Laboratories (MLAB) United States $0.717B 16.91
IRadimed (IRMD) United States $0.693B 37.43
AxoGen (AXGN) United States $0.688B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.666B 0.00
Semler Scientific (SMLR) United States $0.573B 30.14
SiBone (SIBN) United States $0.556B 0.00
OrthoPediatrics (KIDS) United States $0.542B 0.00
Pacific Biosciences Of California (PACB) United States $0.540B 0.00
Treace Medical Concepts (TMCI) United States $0.434B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.408B 22.08
AngioDynamics (ANGO) United States $0.361B 0.00
Delcath Systems (DCTH) United States $0.352B 0.00
NeuroPace (NPCE) United States $0.344B 0.00
CVRx (CVRX) United States $0.294B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Inogen (INGN) United States $0.202B 0.00
Accuray (ARAY) United States $0.186B 0.00
KORU Medical Systems (KRMD) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.181B 0.00
Nevro (NVRO) United States $0.142B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
Spectral Diagnostics (EDTXF) Canada $0.091B 0.00
LENSAR (LNSR) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
908 Devices (MASS) United States $0.072B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.064B 0.00
WORK Medical Technology Group (WOK) China $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Neuronetics (STIM) United States $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.023B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.009B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00